These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15757201

  • 1. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [Abstract] [Full Text] [Related]

  • 2. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004; 55(4):133-41. PubMed ID: 15757200
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Satacińska-Los E, Kulig A, Włoch J.
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [Abstract] [Full Text] [Related]

  • 4. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Włoch J, Sałacińska-Los E, Kulig A, Jarzab B.
    Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
    [Abstract] [Full Text] [Related]

  • 5. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.
    Pol J Pathol; 2003 Feb; 54(2):111-5. PubMed ID: 14575419
    [Abstract] [Full Text] [Related]

  • 7. Retinoblastoma expression in thyroid neoplasms.
    Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP.
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM.
    Pathol Res Pract; 2009 May; 205(2):83-7. PubMed ID: 18996649
    [Abstract] [Full Text] [Related]

  • 9. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
    West J, Munoz-Antonia T, Johnson JG, Klotch D, Muro-Cacho CA.
    Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
    [Abstract] [Full Text] [Related]

  • 11. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF.
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
    Lewy-Trenda I, Bieńkiewicz M.
    Pol J Pathol; 1999 Nov; 50(3):129-38. PubMed ID: 10624114
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [Abstract] [Full Text] [Related]

  • 14. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O.
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [Abstract] [Full Text] [Related]

  • 16. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.
    Cancer Res; 1998 Jul 15; 58(14):3015-20. PubMed ID: 9679965
    [Abstract] [Full Text] [Related]

  • 17. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E, Cyniak-Magierska A, Sporny S, Pastuszak-Lewandoska D, Lewiński A.
    Neuro Endocrinol Lett; 2007 Aug 15; 28(4):341-50. PubMed ID: 17693985
    [Abstract] [Full Text] [Related]

  • 18. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A.
    Mod Pathol; 2000 Aug 15; 13(8):882-7. PubMed ID: 10955455
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
    Omar E, Madhavan M, Othman NH.
    Pathology; 2004 Apr 15; 36(2):152-9. PubMed ID: 15203751
    [Abstract] [Full Text] [Related]

  • 20. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2005 Apr 15; 25(1A):179-82. PubMed ID: 15816536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.